Evidence map›Paper›PMID 37604819›Full record

ArticleNature communications2023

Environmental and genetic predictors of human cardiovascular ageing.

Mit Shah, Marco H de A Inácio, Chang Lu, Pierre-Raphaël Schiratti, Sean L Zheng, Adam Clement, Antonio de Marvao, Wenjia Bai, Andrew P King, James S Ware and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. How to measure and model cardiovascular aging.Cardiovascular research · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Mit ShahMRC London Institute of Medical Sciences, Imperial College London, London, UK.
Marco H de A InácioMRC London Institute of Medical Sciences, Imperial College London, London, UK.
Chang LuMRC London Institute of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-3272-0120
Pierre-Raphaël SchirattiMRC London Institute of Medical Sciences, Imperial College London, London, UK.
Sean L ZhengNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-5762-6392
Adam ClementMRC London Institute of Medical Sciences, Imperial College London, London, UK.
Antonio de MarvaoMRC London Institute of Medical Sciences, Imperial College London, London, UK.
Wenjia BaiDepartment of Computing, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-2943-7698
Andrew P KingSchool of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-9965-7015
James S WareMRC London Institute of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6110-5880
Martin R WilkinsNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-3926-1171
Johanna MielkeBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.ORCID http://orcid.org/0000-0002-4239-5499
Eren ElciBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.
Ivan KryukovBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.
Kathryn A McGurkMRC London Institute of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-5445-6906
Christian BenderBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.ORCID http://orcid.org/0000-0003-2630-1453
Daniel F FreitagBayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.ORCID http://orcid.org/0000-0003-0857-8950
Declan P O'ReganMRC London Institute of Medical Sciences, Imperial College London, London, UK. declan.oregan@imperial.ac.uk.ORCID http://orcid.org/0000-0002-0691-0270
MRC London Institute of Medical Sciences · GBBayer (Germany) · DEImperial College London · GBKing's College London · GB

Funding

British Heart Foundation RG/19/6/34387Department of HealthMedical Research Council MC_UP_1102/19Medical Research Council MC_UP_1102/20Medical Research Council MC_UP_1605/13
6 · The paper itself

Abstract

Cardiovascular ageing is a process that begins early in life and leads to a progressive change in structure and decline in function due to accumulated damage across diverse cell types, tissues and organs contributing to multi-morbidity. Damaging biophysical, metabolic and immunological factors exceed endogenous repair mechanisms resulting in a pro-fibrotic state, cellular senescence and end-organ damage, however the genetic architecture of cardiovascular ageing is not known. Here we use machine learning approaches to quantify cardiovascular age from image-derived traits of vascular function, cardiac motion and myocardial fibrosis, as well as conduction traits from electrocardiograms, in 39,559 participants of UK Biobank. Cardiovascular ageing is found to be significantly associated with common or rare variants in genes regulating sarcomere homeostasis, myocardial immunomodulation, and tissue responses to biophysical stress. Ageing is accelerated by cardiometabolic risk factors and we also identify prescribed medications that are potential modifiers of ageing. Through large-scale modelling of ageing across multiple traits our results reveal insights into the mechanisms driving premature cardiovascular ageing and reveal potential molecular targets to attenuate age-related processes.

Indexed as

AgingAging, PrematureCellular SenescenceElectrocardiographyHumansMyocardium

Identifiers

PMID37604819
PMCPMC10442405
OpenAlexW4386033479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.